Type I |
Type II | |
Previous history of thyroid disease |
Multinodular goiter or Graves disease (usually undiagnosed) |
None |
Pathomechanism |
Excess iodine causing increased synthesis of thyroid hormones (3 mg of inorganic iodine per 100 mg of amiodarone with typical diet including <0.5 mg of iodine/d) |
Toxic effect of amiodarone (inflammation) causing damage of thyroid cells and release of thyroid hormones |
Iodine uptake |
>5% |
<2% |
Color flow thyroid Doppler ultrasonography |
Thyroid gland frequently enlarged, nodules may be present; increased blood flow |
Normal appearance of thyroid gland; significantly decreased/absent blood flow |
TRAb |
Increased in Graves disease |
Negative |
Pharmacologic treatmenta |
Eg, methimazole 40-60 mg/d + sodium perchlorate (<4 weeks) 200-250 mg qid (inhibits iodine accumulation in thyroid gland); consider radical treatment |
For instance, prednisone 40-60 mg/d for 1-3 months, then taper off the dose over another 2 months |
a When differential diagnosis of these types is impossible and thyroid status from before amiodarone use is unknown, combined treatment can be used: start with methimazole; add glucocorticoids if there is no improvement. | ||
qid, 4 times a day; TRAb, thyroid-stimulating hormone receptor antibodies. |